Unsere Portfoliounternehmen

Aktuelle Beteiligungen

Ausgewählte Exits

Auszug veräußerte Beteiligungen

EIT Emerging Implant Technologies GmbH

Company with best in class 3D-printed spine cages

Exited to Johnson & Johnson

Novosis AG

Drug delivery company with exceptional knowledge in transdermal drug delivery technologies

Exited to Acino (formerly Schweizerhall)

ProBioGen AG

Renown CDMO company with longstanding experience in cell line development and production optimization

Acquired by Minapharm Pharmaceuticals

TNI medical AG

Leading company in the innovative highflow therapy area for non-invasive ventilation

Acquired by Masimo

Vita 34 AG

Successful pioneer in cryoconservation of stem cells of the cord blood

IPO (prime market at the German stock exchange)